AAP eBooks
Advanced Search

Pediatric Psychopharmacology for Primary Care, 2nd ed.

By Mark A. Riddle, MD
Citation Manager
Share

Completely updated and revised, the second edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders.

Show More Show Less
  1. Page xi
    Introduction
    1. Page xi
      What Is This Book?
    2. Page xi
      Selected Updates in Second Edition
    3. Page xii
      Target Audience
    4. Page xiii
      Why Now?
    5. Page xiv
      Basic Principles
    6. Page xv
      What About the Future?
  2. Page xvi
    References
  3. Page 1
    Part I. Conceptual Framework
    1. Page 3
      1. Conceptual Framework for Prescribing Psychotropic Medications
      1. Page 3
        Rationale for the Conceptual Framework
      2. Page 6
        Group 1 Medications for Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression
      3. Page 11
        Group 2 Medications
      4. Page 13
        Group 3 Medications
    2. Page 13
      References
  4. Page 15
    Part II. Practical Guidance
    1. Page 17
      2. The Psychosocial Assessment in Primary Care
      1. Page 18
        Start With Inquiry About Normative Developmental Trajectory
      2. Page 18
        Triage for Psychiatric and Social Emergencies
      3. Page 19
        Emphasize Function
      4. Page 20
        Assess Sleep Pattern
      5. Page 21
        Identify Environmental Stressors
      6. Page 22
        Screen for Substance Use
      7. Page 22
        Differentiate New Problems From Exacerbation of Old or Chronic Problems
      8. Page 23
        Inquire About Prior Evaluations and Prior and Current Treatments
      9. Page 23
        Provide Initial Primary Care Intervention for Problems That Are Not Disorders
      10. Page 24
        Provide Extended Evaluations and Interim Check-ins, if Needed
      11. Page 24
        Preparing the Practice
    2. Page 25
      References
    3. Page 27
      3. Assessment of Disorders, Formulation, and Feedback
      1. Page 27
        Overview
      2. Page 27
        Assessment
      3. Page 47
        Determine if Medication Is Indicated
      4. Page 48
        Recognize Need for Referral
      5. Page 50
        Formulation
      6. Page 50
        Feedback
    4. Page 53
      References
    5. Page 55
      4. Before Prescribing
      1. Page 55
        Nonmedication Interventions
      2. Page 59
        Informed Consent
      3. Page 61
        Specific Consent Issues
      4. Page 64
        Off-label Prescribing
      5. Page 64
        US Food and Drug Administration Boxed Warnings
      6. Page 66
        Important Considerations for Safe and Effective Prescribing
    6. Page 67
      References
  5. Page 71
    Part III. Group 1 Medications for Specific Diagnoses: Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression
    1. Page 73
      5. Group 1 Medications for Attention Deficit/Hyperactivity Disorder
      1. Page 73
        General Guidance
      2. Page 77
        Methylphenidate
      3. Page 85
        Amphetamine
      4. Page 93
        Guanfacine
      5. Page 100
        Clonidine
      6. Page 107
        Atomoxetine
      7. Page 112
        Summary
    2. Page 113
      References
    3. Page 115
      6. Group 1 Medications for Anxiety and Depression
      1. Page 115
        General Guidance
      2. Page 119
        Group 1 Selective Serotonin Reuptake Inhibitors
      3. Page 127
        Group 1 Serotonin and Norepinephrine Reuptake Inhibitor: Duloxetine
      4. Page 131
        Summary
    4. Page 132
      References
  6. Page 133
    Part IV. Group 2 (FDA-Approved Antipsychotics and Mood Stabilizers) and Group 3 (All Other) Medications
    1. Page 135
      7. Group 2 Medications: Antipsychotics and Mood Stabilizers
      1. Page 135
        Rationale
      2. Page 136
        Antipsychotics
      3. Page 147
        The Mood Stabilizer Lithium
      4. Page 154
        Summary
    2. Page 155
      References
    3. Page 157
      8. Group 3 Medications
      1. Page 157
        Other Antidepressants
      2. Page 163
        Other Antipsychotics
      3. Page 164
        Other Mood Stabilizers
      4. Page 164
        Anxiolytics
      5. Page 164
        Sleep Aids
      6. Page 166
        Future Considerations
    4. Page 166
      References
  7. Page 167
    Part V. Advanced Topics
    1. Page 169
      9. What to Do When Treatment Is Not Successful
      1. Page 169
        Understand the Limits of Evidence-Based Treatments and Protocols
      2. Page 169
        Reassess Diagnoses
      3. Page 172
        Reassess Psychosocial Risks and Protective Factors
      4. Page 173
        Reevaluate Psychotherapies
      5. Page 174
        Reconsider Medication
      6. Page 175
        Discontinuing Group 1 Medications
      7. Page 175
        Switching Group 1 Medications
      8. Page 176
        When to Consider Group 2 Antipsychotics or Lithium
      9. Page 178
        When to Consider Group 3 Medications Without FDA Approval for Use in Youth
      10. Page 178
        When to Consider Drug Levels or Genetic Testing
      11. Page 179
        Can Genotyping Improve Medication Response?
      12. Page 198
        When to Consider Consultation or a Second Opinion
      13. Page 198
        When to Consider Referral for All or Part of the Patient’s Ongoing Behavioral Health Care
    2. Page 198
      References
  8. Page 183
    Appendixes
  9. Page 185
    Appendix A: Assessment and Symptom Monitoring Tools
  10. Page 205
    Appendix B: Resources for Clinicians
  11. Page 213
    Appendix C: Training Resources for Clinicians
  12. Page 215
    Appendix D: Quality Ratings for Psychotherapies and Efficacy Data for Medications
  13. Page 221
    Appendix E: Resources for Caregivers
  14. Page 223
    Appendix F: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnoses
  15. Page 231
    Index

More From Primary Care

Citation Manager
Share

AAP eBooks Notices

COVID-19 Resources

The AAP offers a COVID-19 web page where you can find the latest clinical guidance, information on PPE, practice management resources, including telehealth and coding. This page is updated daily and is the best place to locate AAP resources. 

Neonatal Resuscitation (NRP®) eBook Collection
The Neonatal Resuscitation (NRP®) eBook Collection is available exclusively from the AAP. The Textbook of Neonatal Resuscitation®, 8th Edition is now available and will automatically be added to your eBook collection along with changes in the bonus titles.

AAP 90th Anniversary Publication
Learn about the history of the AAP: The American Academy of Pediatrics: 90 Years of Caring for Children 1930-2020

Try Our Enhanced Search
Search for topics in eBooks, Journals, or News right from the search bar. Try it now!

Reader Apps Available
Free apps for iOS or Android smartphones and tablets for offline eBook reading. For more information, click here.

AAP Point-of-Care Solutions

Five essential AAP resources share an integrated platform, with quick, easy access to well-care guides, acute-care answers, patient education, tool and resource collections, and pediatric coding.

AAP journals and AAP News are available on Gateway, a seamless, relevant reading experience on any mobile device.

Explore